<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9508162</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20933</journal-id>
<journal-id journal-id-type="nlm-ta">Inflamm Bowel Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Inflamm. Bowel Dis.</journal-id>
<journal-title-group>
<journal-title>Inflammatory bowel diseases</journal-title>
</journal-title-group>
<issn pub-type="ppub">1078-0998</issn>
<issn pub-type="epub">1536-4844</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27753692</article-id>
<article-id pub-id-type="pmc">5082182</article-id>
<article-id pub-id-type="doi">10.1097/MIB.0000000000000936</article-id>
<article-id pub-id-type="manuscript">NIHMS814894</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Serologic Anti-GP2 Antibodies are Associated with Genetic Polymorphisms, Fibrostenosis and Need for Surgical Resection in Crohnâ€™s Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Degenhardt</surname>
<given-names>Frauke</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dirmeier</surname>
<given-names>Andrea</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lopez</surname>
<given-names>Rocio</given-names>
</name>
<degrees>M.S.</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lang</surname>
<given-names>Sylvia</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kunst</surname>
<given-names>Claudia</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roggenbuck</surname>
<given-names>Dirk</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reinhold</surname>
<given-names>Dirk</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Szymczak</surname>
<given-names>Silke</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rogler</surname>
<given-names>Gerhard</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Klebl</surname>
<given-names>Frank</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Franke</surname>
<given-names>Andre</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rieder</surname>
<given-names>Florian</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany</aff>
<aff id="A2"><label>2</label>Department of Internal Medicine I, University Medical Center Regensburg, Regensburg, Germany</aff>
<aff id="A3"><label>3</label>Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, USA</aff>
<aff id="A4"><label>4</label>Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland</aff>
<aff id="A5"><label>5</label>Faculty of Science, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany</aff>
<aff id="A6"><label>6</label>Institute of Molecular and Clinical Immunology, Otto-von-Guericke University Magdeburg</aff>
<aff id="A7"><label>7</label>Institute of Medical Informatics and Statistics, Christian-Albrechts-University of Kiel, Kiel, Germany</aff>
<aff id="A8"><label>8</label>Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland</aff>
<aff id="A9"><label>9</label>Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic Foundation, Cleveland, USA</aff>
<author-notes>
<corresp id="cor1"><bold>Reprint requests and correspondence:</bold> Dr. Florian Rieder, Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, Phone: 216-445-4916, Fax: 216-636-0104, <email>riederf@ccf.org</email></corresp>
<fn fn-type="equal" id="FN1">
<label>*</label>
<p id="P1">both authors contributed equally</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>8</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>11</month>
<year>2017</year>
</pub-date>
<volume>22</volume>
<issue>11</issue>
<fpage>2648</fpage>
<lpage>2657</lpage>
<!--elocation-id from pubmed: 10.1097/MIB.0000000000000936-->
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P2">The presentation of Crohn`s disease (CD) is heterogeneous and often leads to serious complications and need for surgery. We tested serum anti-zymogen granule glycoprotein 2 (GP2) antibodies, including its novel isoform alpha, for association with genetic variants, diagnosis, disease stratification and prediction of CD courses in a combined cross sectional and cohort study.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P3">Serum samples of 303 CD, 108 ulcerative colitis (UC), 72 other inflammatory gastrointestinal diseases (OGD) and 206 non GI diseases controls (HC) were tested for the presence of Anti-GP2 and Anti-<italic>saccharomyces cervisiae</italic> (ASCA) by ELISA. Genetic analysis was performed using the Illumina Immunochip.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P4">GP2 IgA and IgG had the highest discriminatory capability for CD versus UC and CD versus OGD. We identified an association of GP2 IgA and IgG each with 5 distinct SNPs. Levels of anti-GP2 IgG were moderately associated with ileal disease location. Interestingly, both, anti-GP2 IgA and IgG were exclusively associated with the occurrence of stenosis and need for surgery, independently of disease location, but not with fistulizing CD, early disease onset or disease activity. ASCA IgG and IgA were qualitatively and quantitatively linked to CD, CD complications and need for surgery. Increased levels of ASCA IgG and IgA and positivity for ASCA IgG, but neither levels nor positivity for GP2 IgG or IgA were predictive of the earlier occurrence of complications or surgery.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P5">Anti-GP2 antibodies may aid as a tool for diagnosis and differentiation of CD and could indicate a more complicated CD course.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Serum antibody</kwd>
<kwd>fibrosis</kwd>
<kwd>stricture</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>